Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.112106
Revised: September 1, 2025
Accepted: October 11, 2025
Published online: November 14, 2025
Processing time: 118 Days and 3.9 Hours
Endoscopic retrograde appendicitis therapy (ERAT) offers an appendix-pre
To assess the efficacy and feasibility of EDAT and compare them with those of ERAT in uncomplicated appen
In this retrospective cohort study, patients diagnosed with uncomplicated appendicitis and treated with ERAT or EDAT between January 2021 and November 2024 were reviewed. The primary outcome was intervention success. Secondary outcomes were guidewire use, stent placement, hospitalization duration, recurrence, and endoscopic direct-view features. Outcomes were compared between groups via appropriate statistical tests.
Of 170 patients, 136 underwent EDAT and 34 ERAT. EDAT showed higher intervention success than ERAT (99.3% vs 82.4%, P < 0.001), with less guidewire assistance and fewer stent placements (both P < 0.001). Hospital stay was shorter with EDAT (P = 0.039). The overall cumulative recurrence rates at 1 year were 10% in EDAT and 24% in ERAT; in the appendicolith subgroup, the recurrence rates were 5% and 14% in EDAT and ERAT, respectively. Findings were consistent in the propensity score-matched (PSM) cohort.
EDAT was demonstrated to be a more effective and feasible approach than ERAT, with a lower overall cumulative recurrence risk and within the appendicolith subgroup. Consistent results after PSM further supported the robust
Core Tip: Endoscopic direct appendicitis therapy (EDAT) shows clear clinical advantages over endoscopic retrograde appendicitis therapy (ERAT) in the management of uncomplicated appendicitis. EDAT achieved significantly higher intervention success and lower recurrence rates, including in patients with appendicoliths, a subgroup at a high risk of antibiotic treatment failure. It also shortens hospital stay and stent replacement, improving procedural efficiency. As the first head-to-head comparison of EDAT and ERAT, this study provided novel evidence supporting EDAT as a more effective, minimally invasive option, with important implications for evolving non-surgical management strategies.
